| 000 | 01662 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513213151.0 | ||
| 264 | 0 | _c20001213 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a1055-9965 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aProbst-Hensch, N M | |
| 245 | 0 | 0 |
_aN-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. _h[electronic resource] |
| 260 |
_bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _cJun 2000 |
||
| 300 |
_a619-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcetylation |
| 650 | 0 | 4 |
_aAcetyltransferases _xgenetics |
| 650 | 0 | 4 |
_aAminobiphenyl Compounds _xadverse effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aDNA Adducts _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHemoglobins |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xchemically induced |
| 700 | 1 | _aBell, D A | |
| 700 | 1 | _aWatson, M A | |
| 700 | 1 | _aSkipper, P L | |
| 700 | 1 | _aTannenbaum, S R | |
| 700 | 1 | _aChan, K K | |
| 700 | 1 | _aRoss, R K | |
| 700 | 1 | _aYu, M C | |
| 773 | 0 |
_tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _gvol. 9 _gno. 6 _gp. 619-23 |
|
| 999 |
_c10819496 _d10819496 |
||